South Korea - Lipid Modifying Medicine Use
Since 2014, South Korea Lipid Modifying Medicine Use was up 7% year on year. With 72.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 24 among other countries in Lipid Modifying Medicine Use. South Korea is overtaken by Latvia, which was number 23 with 80.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Estonia at 66.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.5% compared to 2018. United Kingdom, Belgium and Norway respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +15% per year, while Slovakia was the worst growing country at -7% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 72.90 |
| 2018 | 70.30 |
| 2017 | 68.70 |
| 2016 | 64.90 |
| 2015 | 58.80 |
How does South Korea rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
| 23 |
#23
Latvia
|
80 | 2019 | +3.5 % | +7.4 % | View data | |
| 24 |
#24
South Korea
|
73 | 2019 | +3.7 % | +7.0 % | View data | |
| 25 |
#25
Estonia
|
67 | 2019 | +2.9 % | +7.0 % | View data | |